FDA Approves Expanded Uses for GARDASIL in Preventing Cancer

  • Share
    Share Video

  • Add
  • More
    Report this video as:
0 0
You have already voted for this video.
September 12, 2008 – The U.S. Food and Drug Administration today announced the approval of the vaccine GARD...
September 12, 2008 – The U.S. Food and Drug Administration today announced the approval of the vaccine GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant] for the prevention of vaginal and vulvar cancer caused by Human Papillomavirus (HPV) types 16 and 18 in girls and women ages 9 to 26. These two HPV types cause 70 percent of cervical cancers, and are known to also cause some vulvar and vaginal cancers, but the percentages are not well defined.
Categories:
Related